Synairgen plc (SYGGF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Jan 16, 2026, 9:30 AM EST
Synairgen Market Cap
Synairgen has a market cap or net worth of $110.27 thousand as of January 23, 2026. Its market cap has decreased by -99.77% in one year.
Market Cap
110.27K
Enterprise Value
-5.59M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since July 20, 2020, Synairgen's market cap has decreased from 375.08M to 110.27K, a decrease of -99.97%. That is a compound annual growth rate of -77.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 110.27K | 9,896.92% |
| Dec 30, 2025 | 1.10K | -99.98% |
| Dec 31, 2024 | 5.78M | -42.64% |
| Dec 29, 2023 | 10.07M | -59.68% |
| Dec 30, 2022 | 24.97M | -95.55% |
| Dec 31, 2021 | 560.74M | 40.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CNBX Pharmaceuticals | 217.69K |
| Endonovo Therapeutics | 180.76K |
| Nascent Biotech | 138.27K |
| Scorpius Holdings | 122.29K |
| Eastgate Biotech | 105.79K |
| Ocean Biomedical | 92.95K |
| Vincerx Pharma | 65.69K |
| Affymax | 59.59K |